Form 4 for DGX Quest Diagnostics
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-06 · accession 0001497368-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-08 | 2025-08-06 | DGX | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $175.00 | -5,535 | 21.2K | -21% | -$968.6K |
| D | 2025-08-08 | 2025-08-06 | DGX | Plewman Patrick | SVP for Diagnostic Services | M - OptEx | $86.63 | +3,560 | 24.7K | +17% | +$308.4K |
| D | 2025-08-08 | 2025-08-06 | DGX | Plewman Patrick | SVP for Diagnostic Services | M - OptEx | $86.63 | -3,560 | 0 | -100% | -$308.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-06 | S | D | 1,975 | $175.00 | 19,219 | D | — | — | (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| 2 | Common | Common Stock | 2025-08-06 | S | D | 3,560 | $175.00 | 21,185 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-06 | M | A | 3,560 | $86.63 | 24,745 | D | — | — | |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2025-08-06 | M | D | 3,560 | $86.63 | 0 | D | $86.63 · — to 2029-02-18 | 3,560 Common Stock | (F3) The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. |